AIDS alert

(ISSN: 0887-0292)

Table of Contents

2008 - 23 (3)

  • FDA notifications. Changes to ART guidelines detailed by the FDA. 
  • FDA notifications. Pediatric formulation of lamivudine approved. 
  • FDA notifications. Revised atazanavir package insert. 
  • FDA notifications. FDA grants accelerated approval for etravirine. 
  • FDA notifications. Generic lamivudine tentatively approved. 
  • FDA notifications. FDA tentatively approves generic atazanavir. 
  • Status report on the female condom: what will increase use in the U.S.? 
  • Late diagnosis/entry into HIV care can result in early deaths among infected. Study highlights human year toll. 
  • Positive results involving HIV prevention for the mentally ill population. Motivational interviewing is used. 
  • Full viral suppression newest trend seen in the "post-HAART" era. New immunotherapy treatment could help with trend. 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.